{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:12:33Z","timestamp":1766009553976,"version":"3.48.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032743","name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Progressive myoclonic epilepsies (PME) are rare genetic disorders typically presenting with myoclonus, seizures, and cognitive decline. While several genes are associated with PME, the\n                      <jats:italic>NUS1<\/jats:italic>\n                      gene has recently emerged as a potential cause. We report the case of a 41-year-old woman who presented with tics, myoclonus, and language difficulties followed by gait instability, tremor, absence seizures, and psychotic symptoms including persistent hallucinations and delusional misidentification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Neurology and psychiatry specialists reviewed clinical data. Brain MRI, scalp video-EEG monitoring, and [18F]-FDG-PET\/MRI were performed following standardized protocols. Whole exome sequencing (WES) guided by human phenotype ontology (HPO) terms was performed, and variants were interpreted according to American College of Medical Genetics and Genomics (ACMG) guidelines. Additionally, we conducted a review of previously reported cases of\n                      <jats:italic>NUS1<\/jats:italic>\n                      pathogenic\/likely pathogenic variants associated with PME to better characterize the clinical and paraclinical features and to explore potential management strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A novel heterozygous frameshift likely pathogenic variant in the\n                      <jats:italic>NUS1<\/jats:italic>\n                      gene, c.248del, p. (His83Profs*22), was identified in the patient. This finding led to the introduction of a targeted therapeutic strategy, including the initiation of metformin and a thorough revision of the patient\u2019s existing psychiatric treatment. The patient showed an improvement in her psychiatric manifestations. However, neurological examination revealed either stable or slightly worsened signs, and she did not achieve seizure freedom.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This is the first review of\n                      <jats:italic>NUS1<\/jats:italic>\n                      from a PME perspective and the first report describing the exploratory use of metformin as a potential therapeutic intervention. In our case, metformin was introduced simultaneously with a change in antipsychotic treatment, so its specific clinical impact cannot be determined. Additional studies are needed to improve understanding of the benefits of using metformin and other therapeutic strategies in\n                      <jats:italic>NUS1<\/jats:italic>\n                      -related disorders. Further studies are essential to clarify the full phenotypic spectrum associated with\n                      <jats:italic>NUS1<\/jats:italic>\n                      variants and to improve our understanding of how specific variant types and locations contribute to clinical presentation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1665623","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:10:13Z","timestamp":1766009413000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the spectrum of NUS1-related progressive myoclonic epilepsy: a novel variant and exploratory use of metformin"],"prefix":"10.3389","volume":"16","author":[{"given":"Cristina","family":"Sau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"L\u00f3pez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Falip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Esteve-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacint","family":"Sala-Padr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthia","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Navarro-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Lasa-Aranzasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rodr\u00edguez-Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106371","DOI":"10.1016\/j.eplepsyres.2020.106371","article-title":"NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor","volume":"164","author":"Araki","year":"2020","journal-title":"Epilepsy Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJM198607313150506","article-title":"Progressive myoclonus epilepsies: specific causes and diagnosis","volume":"315","author":"Berkovic","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/ijms26041471","article-title":"Niemann-pick C-like endolysosomal dysfunction in DHDDS patient cells, a congenital disorder of glycosylation, can be treated with miglustat","volume":"26","author":"Best","year":"2025","journal-title":"IJMS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.27272","article-title":"The spectrum of neurologic phenotypes associated with NUS1 pathogenic variants: a comprehensive case series","volume":"98","author":"Brooker","year":"2025","journal-title":"Ann. Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s13311-022-01304-w","article-title":"Early treatment with metformin improves neurological outcomes in lafora disease","volume":"20","author":"Burgos","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/epd2.20152","article-title":"ILAE genetics literacy series: progressive myoclonus epilepsies","volume":"25","author":"Cameron","year":"2023","journal-title":"Epileptic Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1212\/NXG.0000000000000641","article-title":"Progressive myoclonus epilepsies: diagnostic yield with next-generation sequencing in previously unsolved cases","volume":"7","author":"Canafoglia","year":"2021","journal-title":"Neurol. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajhg.2021.03.013","article-title":"Progressive myoclonus epilepsies\u2014Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes","volume":"108","author":"Courage","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12883-019-1489-x","article-title":"Recurrent NUS1 canonical splice donor site mutation in two unrelated individuals with epilepsy, myoclonus, ataxia and scoliosis - a case report","volume":"19","author":"Den","year":"2019","journal-title":"BMC Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1557103","DOI":"10.3389\/fped.2025.1557103","article-title":"Case Report: de novo variant of the NUS1 gene associated with developmental delay and autism spectrum disorders in a Chinese family","volume":"13","author":"Ding","year":"2025","journal-title":"Front. Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/cge.13867","article-title":"Psychosis in NUS1 de novo mutation: new phenotypical presentation","volume":"99","author":"Fraiman","year":"2021","journal-title":"Clin. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1212\/WNL.0000000000000077","article-title":"Progressive myoclonic epilepsies: definitive and still undetermined causes","volume":"82","author":"Franceschetti","year":"2014","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/cjn.2020.204","article-title":"Generalized dystonia as a prominent feature in a case of NUS1 gene mutation","volume":"48","author":"Gunzler","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100405","DOI":"10.1016\/j.ebr.2020.100405","article-title":"A patient with a 6q22.1 deletion and a phenotype of non-progressive early-onset generalized epilepsy with tremor","volume":"15","author":"Haginoya","year":"2021","journal-title":"Epilepsy & Behav. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ajhg.2017.09.008","article-title":"High Rate of Recurrent de novo Mutations in Developmental and Epileptic Encephalopathies","volume":"101","author":"Hamdan","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbr.2011.01.034","article-title":"The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone","volume":"220","author":"Horisawa","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1224949","DOI":"10.3389\/fgene.2023.1224949","article-title":"Case report: splicing effect of a novel heterozygous variant of the NUS1 gene in a child with epilepsy","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/WNR.0b013e328352de40","article-title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux","volume":"23","author":"Huang","year":"2012","journal-title":"NeuroReport"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s10072-023-06851-4","article-title":"Novel NUS1 variant in a Chinese patient with progressive myoclonus epilepsy: a case report and systematic review","volume":"44","author":"Ji","year":"2023","journal-title":"Neurol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ijms21041335","article-title":"Mechanisms and regulation of nonsense-mediated mRNA decay and nonsense-associated altered splicing in lymphocytes","volume":"21","author":"Lambert","year":"2020","journal-title":"IJMS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2024.11.012","article-title":"Case series; NUS1 deletions cause a progressive myoclonic epilepsy with ataxia","volume":"124","author":"Landais","year":"2025","journal-title":"Seizure"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1373448","DOI":"10.3389\/fgene.2024.1373448","article-title":"Case report: novel NUS1 variant in a Chinese patient with tremors and intellectual disability","volume":"15","author":"Li","year":"2024","journal-title":"Front. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.3390\/ijms25168884","article-title":"Metformin lysosomal targeting: a novel aspect to be investigated for metformin repurposing in neurodegenerative diseases?","volume":"25","author":"Papini","year":"2024","journal-title":"IJMS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cmet.2014.06.016","article-title":"Mutation of Nogo-B receptor, a subunit of cis-Prenyltransferase, causes a congenital disorder of glycosylation","volume":"20","author":"Park","year":"2014","journal-title":"Cell Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5334\/tohm.696","article-title":"NUS1 and epilepsy-myoclonus-ataxia syndrome: an under-recognized entity?","volume":"12","author":"Riboldi","year":"2022","journal-title":"Tremor Other Hyperkinetic Movements"},{"key":"B27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1007\/s12035-024-04123-6","article-title":"NUS1 variants cause lennox-gastaut syndrome related to unfolded protein reaction activation","volume":"61","author":"Shen","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ejhg.2014.75","article-title":"6q22.1 microdeletion and susceptibility to pediatric epilepsy","volume":"23","author":"Szafranski","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/mds.27412","article-title":"Progressive myoclonus ataxia: time for a new definition?","volume":"33","author":"Van Der Veen","year":"2018","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"106555","DOI":"10.1016\/j.nbd.2024.106555","article-title":"The natural history of progressive myoclonus ataxia","volume":"199","author":"Van Der Veen","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mdc3.13920","article-title":"DHDDS and NUS1: a converging pathway and common phenotype","volume":"11","author":"Williams","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/070674370705200708","article-title":"Clozapine-induced seizures: Recognition and treatment","volume":"52","author":"Wong","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41436-021-01137-6","article-title":"Lysosomal cholesterol accumulation contributes to the movement phenotypes associated with NUS1 haploinsufficiency","volume":"23","author":"Yu","year":"2021","journal-title":"Genet. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"725231","DOI":"10.3389\/fped.2021.725231","article-title":"Case report: clinical features of a Chinese boy with epileptic seizures and intellectual disabilities who carries a truncated NUS1 variant","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/genes15020171","article-title":"Progressive myoclonus epilepsy: a scoping review of diagnostic, phenotypic and therapeutic advances","volume":"15","author":"Zimmern","year":"2024","journal-title":"Genes"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1665623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:10:13Z","timestamp":1766009413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1665623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":36,"alternative-id":["10.3389\/fgene.2025.1665623"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1665623","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1665623"}}